# CARBOGEN AMCIS invests over CHF 100M in Switzerland and France

CARBOGEN AMCIS announces two expansion projects: a new API manufacturing facility in Hunzenschwil, Switzerland (operational by summer 2024) and a new parenteral drug product facility in Riom, France (construction starts January 2021). Total investment exceeds CHF 100 million.

- Type: Expansion
- Announced: 2020-08-17
- Where: Hunzenschwil, Switzerland, Switzerland
- Value: $108.0M (100.0M CHF)
- Starts operating: Jun 2024
- Status: announced
- Products: active pharmaceutical ingredients, parenteral drug products
- Sectors: [Specialty Chemicals](https://endata.com/sectors/specialty-chemicals.md)

## Companies

- [CARBOGEN AMCIS](https://endata.com/companies/49164.md)

## Sources

- [carbogen-amcis.com](https://www.carbogen-amcis.com/newsitems/carbogen-amcis-announces-major-investments), 2020-08-17: "After years of growth, it’s exciting to have reached our current production limits and to be able to expand our facilities and grow our capacity."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.